Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer.

Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer. Cancer Radiother. 2016 Jun 21; Authors: Géraud A, Xu HP, Beuzeboc P, Kirova YM PMID: 27342941 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27342941?dopt=Abstract

Source: Cancer Radiotherapie - June 20, 2016 Category: Cancer & Oncology Authors: Géraud A, Xu HP, Beuzeboc P, Kirova YM Tags: Cancer Radiother Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Herceptin